Next Article in Journal
Photodynamic Therapy in Cancer: Insights into Cellular and Molecular Pathways
Previous Article in Journal
Targeting SLC4A4: A Novel Approach in Colorectal Cancer Drug Repurposing
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Screening of Anti-Hair Loss Plant Raw Materials Based on Reverse Network Pharmacology and Experimental Validation

Beijing Key Laboratory of Plant Resources Research and Development, School of Light Industry Science and Engineering, Beijing Technology and Business University, Beijing 100048, China
*
Author to whom correspondence should be addressed.
Curr. Issues Mol. Biol. 2025, 47(1), 68; https://doi.org/10.3390/cimb47010068
Submission received: 27 December 2024 / Revised: 17 January 2025 / Accepted: 18 January 2025 / Published: 20 January 2025
(This article belongs to the Section Molecular Pharmacology)

Abstract

:
Hair loss is one of the skin conditions that can affect people’s mental health. Plant raw material extracts are of great interest due to their safety. In this study, we utilize reverse network pharmacology to screen for key targets of the Wnt/β-catenin signaling pathway and the TGFβ/BMP signaling pathway, as well as key differential lipids, for plant raw materials selection. The aim is to identify plant raw materials that may have anti-hair loss properties and to validate these findings through cell experiments. Licorice, salvia miltiorrhiza, mulberry leaf, ephedra and curcumae radix were found that may possess anti-hair loss effects. Licorice water extract (LWE), salvia miltiorrhiza water extract (SMWE), mulberry leaf water extract (MLWE), ephedra water extract (EWE) and curcumae radix water extract (CRWE) did not exhibit cytotoxicity on human dermal papilla cells (HDPCs). Through ALP staining, it was found that the expression of ALP in HDPCs treated with LWE, SMWE, MLWE, EWE and CRWE was enhanced. In addition, LWE, SMWE, MLWE, EWE and CRWE have reduced the expression of hair growth inhibitory factor TGF-β1 and inflammatory factor IL-6. Additionally, various water extracts can enhance the secretion of VEGF, with high concentrations of SMWE, EWE and CRWE exhibiting better efficacy. Furthermore, β-catenin, a key factor of the Wnt/β-catenin signaling pathway, was enhanced by LWE, SMWE, MLWE, EWE and CRWE treatment in cultured HDPCs. In conclusion, all five plant raw materials showed some anti-hair loss potential, providing theoretical support for their application in anti-hair loss products.

1. Introduction

Hair is a significant aspect of a person’s overall appearance, and healthy hair symbolizes their unique personality. Hair loss, characterized by thinning hair or a receding hairline, can negatively impact an individual’s self-confidence and may lead to various psychological issues, including anxiety and depression [1,2].
The Wnt/β-catenin signaling pathway is one of the most important signaling pathways for hair follicle development, and various Wnt ligands have promoted the hair growth cycle and hair regrowth by activating β-catenin [3]. Zhou et al. found that the overexpression of Wnt10b leads to the activation of the Wnt/β-catenin signaling pathway, which in turn enhances the proliferation and migration of outer root sheath cells (ORCs) [4]. Furthermore, the upregulation of Wnt3a and Wnt5a accumulated β-catenin and activated the Wnt/β-catenin signaling pathway, which led to a marked increase in the number and size of hair follicles in the mice [5]. The TGF-β family, which includes TGF-β and bone morphogenetic proteins (BMP), serves as a critical regulator of cell proliferation and differentiation. TGF-β facilitates the transition of hair follicles to the regressive phase by inhibiting cell proliferation and inducing apoptosis, whereas BMP is essential in orchestrating the initiation of the anagen phase in hair follicle cycling [6,7]. Regulation of the TGF-β/BMP signaling pathway significantly augments the number of hair follicles in murine models [8]. The downregulation of TGF-β1 stimulates keratinocyte (KC) proliferation and inhibits apoptosis, thereby ameliorating alopecia [9]. Furthermore, BMP6 exerts an inhibitory effect on the activation of hair follicle stem cells and the transition from telogen to anagen in hair follicle cycling in mice [10]. Lipids play structural roles and regulatory roles in the hair follicle. Comprising 0.7% to 1.3% of the total hair composition, they are crucial for maintaining hair integrity [11,12]. Additionally, lipids play a significant role in safeguarding the hair against environmental and chemical damage, and they also act as a barrier to prevent moisture loss [13]. Our group previously conducted a comparative lipidomics analysis of hair root lipids between alopecia patients and healthy controls, identifying 45 differentially expressed lipids. Among these, 10-oxo-nonadecanoic acid, myriocin, Cer(d18:0/22:0), Cer(d18:0/24:0), Cer(d18:0/18:0) and Cer(d18:0/16:0) demonstrated AUC greater than 0.7, suggesting their potential as diagnostic biomarkers or therapeutic targets for alopecia [14].
Currently, the primary pharmacological interventions for hair loss are minoxidil (MNX) and finasteride (FINA). However, these treatments exhibit several drawbacks, including dependency issues, such as hair regrowth following discontinuation of the medication. Additionally, long-term use may lead to potential scalp irritation or allergic reactions, and there is a possibility that these treatments could disrupt the normal hair growth cycle [15,16]. In recent years, with people’s pursuit of natural, safe and healthy products, the use of plant raw material extracts in the treatment of hair loss has become increasingly widespread. The advantages of plant extracts as anti-hair loss raw materials are mainly reflected in their high safety, mild effect and long-lasting effects [17,18].
Network pharmacology, which integrates systems biology and bioinformatics, analyzes the molecular associations between drugs and therapeutic targets to reveal the systemic pharmacological mechanisms of drugs [19]. This approach is widely used in the investigation of the mechanisms underlying the treatment of diseases with herbal medicine, with reverse network pharmacology being one of its significant branches [20,21]. Herbal medicines have the characteristics of multi-target and multi-pathway regulation. Reverse network pharmacology adopts a “targets → compounds → herbal medicines” approach, which enables large-scale screening of compounds from multiple disease targets to discover plant materials with therapeutic potential for treating the disease [21,22].
This study focuses on the targets of key anti-hair loss pathways, namely the Wnt/β-catenin and TGFβ/BMP signaling pathways, as well as key differential lipids, to search for plant raw materials. Utilizing reverse network pharmacology, we systematically screen and validate effective components for hair loss prevention from multiple perspectives, with the aim of identifying plant raw materials most likely to be effective in preventing hair loss.

2. Materials and Methods

2.1. Reverse Collection of Active Ingredients from Key Pathway Targets

The names of the target proteins were entered individually into the HERB database (http://herb.ac.cn/ (accessed on 16 November 2023)) to search for active ingredients associated with these proteins. The active ingredients were then filtered based on the conditions of having a PubChem ID, a molecular weight of 500 or less and complying with the Lipinski’s Rule of Five.

2.2. Reverse Collection of Targets of Action and Active Ingredients from Key Differential Lipids

For the six differential lipids related to hair loss that were previously identified by the research group, the SMILES format of these lipids was obtained from the LIPID MAPS database (https://lipidmaps.org/ (accessed on 11 December 2023)). The SMILES format of the lipids was then input into the Swiss Target Prediction website (http://swisstargetprediction.ch/ (accessed on 11 December 2023)). After retrieving the relevant targets of the lipids, these targets were filtered based on the criterion of probability* > 0. Using ‘Alopecia’ as the keyword, the GeneCards database (https://www.genecards.org/ (accessed on 12 December 2023)) was searched to identify relevant targets. The intersection of the two targets was plotted as a Venn diagram to obtain the intersecting targets. Finally, active ingredients were collected based on these targets, following the same method as in Section 2.1.

2.3. Construction of Key Pathway Targets–Active Ingredients–Plant Raw Materials Network

Plant raw materials that contain active ingredients that met the screening criteria were collected from the HERB database. Subsequently, the targets–active ingredient–plant raw material network diagram was constructed using Cytoscape (3.9.1).

2.4. Construction of Key Differential Lipids–Targets–Active Ingredients–Plant Raw Materials Network

Plant raw materials that contain active ingredients that met the screening criteria were collected from the HERB database. Subsequently, the lipids–targets–active ingredients–plant raw material network diagram was constructed using Cytoscape.

2.5. Sample Preparation

Licorice tablets, Salvia miltiorrhiza tablets, mulberry leaf tablets and curcumae radix tablets were purchased from Jiuzhou Shanghekuan Pharmacy (Wuhan, China) and ephedra tablets were purchased from Renxintang pharmacy (Shenzhen, China). Licorice tablets, Salvia miltiorrhiza tablets, mulberry leaf tablets, ephedra tablets and curcumae radix tablets were crushed and sieved through an 80-mesh sieve. The extraction was performed using ultrasonic extraction at 60 °C for 1 h, following a material-to-liquid ratio of 1:10 (g:mL), repeated twice. The supernatant was collected after centrifugation and concentration and then lyophilized to obtain the aqueous extract powder. Then, take 10 mg of the water extract powder and dissolve it in 10 mL of deionized water, making the concentration of 1 mg/mL for the water extract.

2.6. Cell Culture

Human dermal papilla cells (HDPCs) were purchased from NEWGAINBIO (Wuxi, China). HDPCs were cultured in high-sugar DMEM (Cellmax, Beijing, China) supplemented with 10% FBS (NEWGAINBIO, Wuxi, China), 100 U·mL−1 penicillin G and 100 µg·mL−1 streptomycin 1% double antibody (Gibico, Carlsbad, CA, USA). Cells were maintained in a humidified incubator at 37 °C with 5% CO2. When the cells grew adherently to a confluence greater than 80%, they were digested with trypsin and collected by centrifugation at 1000 rpm for 4 min, then passaged at a ratio of 1:2. Cells in the logarithmic growth phase were used for subsequent experiments.

2.7. Cell Viability Assay

CCK-8 assay (Beyotime, Shanghai, China) was used to detect the effects of Licquorice water extract (LWE), salvia miltiorrhiza water extract (SMWE), mul-berry leaf water extract (MLWE), ephedra water extract (EWE) and curcumae radix water extract (CRWE) on the viability of HDPCs. Logarithmically growing HDPCs were adjusted to a density of 1 × 104 cells per well and inoculated into 96-well plates, with 100 μL per well. The plates were then placed in a cell culture incubator at 37 °C with 5% CO2 for 24 h. Control and experimental groups were set up, respectively, and different concentrations of water extract were added to the experimental group. Each group had 3 replicates and was incubated in the cell culture incubator for 24 h. The absorbance at 450 nm was read using a microplate reader.

2.8. Alkaline Phosphatase (ALP) Staining Assay

The ALP staining kit was acquired from Beyotime (Shanghai, China). Logarithmically growing HDPCs were adjusted to a density of 3 × 104 cells per well and inoculated into 24-well plates, with 500 μL per well. The supernatant was discarded after 24 h of incubation in a cell culture incubator. Add fresh culture medium with different concentrations of water extract solutions according to the experimental groups. After incubating for 72 h, staining occurred according to the kit instructions and capture images using a microscope.

2.9. ELISA Assay

Logarithmically growing HDPCs were adjusted to a density of 7 × 104 cells per well and inoculated into 12-well plates, with 1 mL per well. The supernatant was discarded after 24 h of incubation in a cell culture incubator. According to the experimental groups, 1 mL of fresh culture medium containing different concentrations of the water extract solution was added. To the blank control 1 mL of fresh medium was added, while to the positive control group 1 mL of fresh medium containing 5 μM and 10 μM MNX was added. After continuing the culture for 48 h, the supernatant, with 3 replicates set for each group was collected, and an ELISA kit (Cusabio, Wuhan, China) was utilized to measure the VEGF content.

2.10. Real-Time Quantitative PCR (RT-qPCR)

Gene transcription was quantified by RT-qPCR. Collect cells from each group and extract total RNA according to the kit’s instructions (Omega Bio-Tek, Norcross, GA, USA). Determine the concentration and quality of the RNA and subsequently perform reverse transcription to cDNA following the kit instructions (Accurate Biology, Changsha, China). RT-qPCR experiments were conducted using a three-step protocol, with GAPDH serving as the internal reference. Relative gene expression was calculated by 2−ΔΔCT method. The sequences of the primers utilized are presented in Table 1.

2.11. Western Blot Assay

Collect cells from each group and lyse them on ice using RIPA buffer (Beyotime, Shanghai, China) containing PMSF (Beyotime, Shanghai, China). Centrifuge the lysate to obtain the supernatant, then take an appropriate amount of the sample to determine protein concentration using the BCA assay (Beyotime, Shanghai, China). Add the remaining protein to 5× loading buffer (Beyotime, Shanghai, China). After heating the mixture in a metal bath at 95 °C for 5 min, store it at −80 °C. Following separation of the proteins on a 10% SDS-PAGE gel (Epizyme, Shanghai, China), transfer them to a PVDF membrane (Epizyme, Shanghai, China). Block the membrane with 5% skimmed milk, then incubate it overnight at 4 °C with a specific primary antibody (β-catenin) (Proteintech, IL, USA). Wash the membrane three times with TBST (Biosharp, Anhui, China), allowing 8 min for each wash, and then incubate it with a diluted secondary antibody (Immunoway, San Jose, CA, USA) at room temperature for 90 min. Use ECL reagent (Mi Mouse, Xi’an, China) for luminescent imaging. Employ GAPDH as an internal control and analyze the intensity of the bands using ImageJ software version 1.8.0.

2.12. Statistical Analysis

Statistical analysis was conducted using GraphPad Prism (9.5, GraphPad Software, San Diego, CA, USA), and the data are presented as “mean ± standard deviation”. Comparisons between groups were analyzed using Student’s t-test and visualized with GraphPad Prism A p-value of <0.05 was considered statistically significant, <0.01 was deemed highly statistically significant, and <0.001 was regarded as extremely statistically significant.

3. Results

3.1. Reverse Collection of Active Ingredients from Key Pathway Targets

Based on 17 targets from the Wnt/β-catenin signaling pathway and the TGFβ/BMP signaling pathway—specifically, β-catenin, AXIN2, LEF-1, GSK-3β, Wnt3a, Wnt4, Wnt5a, Wnt7b, Wnt10a, Wnt10b, DKK1, BMP2, BMP4, BMP6, TGF-β1, TGF-β2 and TGF-β3—a total of 941 active components were screened. The information regarding the top eight active components, ranked by degree, is shown in Table 2.

3.2. Reverse Collection of Targets of Action and Active Ingredients from Key Differential Lipids

A total of 137 targets were screened based on key differential lipids. By intersecting these with the 4557 hair loss-related targets obtained from the GeneCards database, we identified 55 targets associated with hair loss, as shown in Figure 1. Among these, 53 targets can be found in the HERB database, as listed in Table S1. A reverse screening identified 3562 active components, with the top eight active components ranked by degree as shown in Table 3.

3.3. Construction of Targets–Active Ingredients–Plant Raw Materials Network

3.3.1. Construction of Key Pathway Targets–Active Ingredients–Plant Materials Network

A total of 941 active ingredients information was collected in HERB, along with 1024 plant materials. The top 60 plant raw materials, ranked by degree value, were selected to construct a key targets–active ingredients–plant raw materials network, as shown in Figure 2. The plant raw materials ranked in the top 17 by degree value are listed in Table 4.

3.3.2. Construction of Targets–Active Ingredients–Plant Raw Materials Network Based on Key Differential Lipids

A total of 3562 active ingredient information was collected in HERB, along with 3485 plant raw materials. The top 30 plant raw materials, ranked by degree value, were selected to construct a key targets–active ingredients–plant raw material network, as shown in Figure 3. The plant raw materials ranked in the top 17 by degree value are listed in Table 5.

3.4. Identification of Key Plant Materials

Based on the key pathways and the key differential lipids, a comprehensive screening of plant raw materials was conducted. As shown in Figure 4, five plant materials with the potential for preventing hair loss were identified: licorice, Salvia miltiorrhiza, mulberry leaf, ephedra and curcumae radix.

3.5. Effect of LWE, SMWE, MLWE, EWE and CRWE on the Cell Viability of HDPCs

To investigate the effect of water extracts with different concentrations on the viability of HDPCs, the CCK-8 method was used to assess the impact of LWE, SMWE, MLWE, EWE and CRWE on the viability of HDPCs. As shown in Figure 5, the cell viability of different water extracts, ranging from 5 μg/mL to 320 μg/mL, exceeds 70%. Overall, none of the individual water extracts exhibited cytotoxic effects to HDPCs.

3.6. LWE, SMWE, MLWE, EWE and CRWE Enhanced the ALP Level in the HDPCs

ALP is a highly expressed dimeric protein that plays an active role in the capabilities of hair papillae and the inductive properties of hair follicles. It has been identified as one of the key markers that promote hair growth [23,24]. The expression of the ALP level in HDPCs was assessed using ALP staining with different water extracts, as shown in Figure 6. The experimental results indicate that the different water extracts significantly promote the expression of ALP compared to the control.

3.7. Promoting Effect of LWE, SMWE, MLWE, EWE and CRWE on Secretion of VEGF in HDPCs

The formation of new blood vessels around hair follicles provides the essential nutrients and oxygen necessary for their development and growth, thereby promoting hair regeneration. VEGF is a key factor that enhances microvascular permeability and angiogenesis [24]. To investigate the effects of different water extracts on the expression of VEGF in HDPCs, we measured the secretion of VEGF in HDPCs treated with different water extracts using the ELISA assay. The results showed that after 48 h of treatment with different water extracts, the expression of VEGF in HDPCs increased to varying degrees compared to the control (Figure 7). Among them, the VEGF expression levels in the water extracts of SMWE, EWE and CRWE showed a dose-dependent increase. The high-dose experimental groups significantly (p < 0.001) enhanced VEGF expression, with increases of 200.95%, 159.11% and 228.3%, respectively.

3.8. Inhibitory Effect of LWE, SMWE, MLWE, EWE and CRWE on Expression of TGF-β1 and IL-6 in HDPCs

The TGF-β family is a group of factors that inhibit hair growth. TGF-β1, one of its subtypes, promotes the transition of hair follicles into the regression phase by inhibiting cell proliferation and inducing apoptosis [25,26,27]. Compared to the control, all five water extracts demonstrated varying degrees of inhibition on the expression of TGF-β1 in HDPCs to varying degrees, which is shown in Figure 8. The low- and high-dose experimental groups of LWE significantly inhibited TGF-β1 expression (p < 0.05) compared to the control (Figure 8a). The high-dose experimental group of SMWE reduced TGF-β1 expression by 31.51% relative to the control, which was more effective than the positive control, MNX (Figure 8b,f). The low-, medium-, and high-dose experimental groups of MLWE significantly inhibited TGF-β1 expression, resulting in reductions of 23.56%, 9.91% and 18.12%, respectively (Figure 8c). The mRNA expression level of TGF-β1 in the EWE experimental group reached its lowest point at a concentration of 5 μg/mL (Figure 8d). The mRNA expression level of TGF-β1 in the CRWE experimental group decreased, but it was not statistically significant (Figure 8e). Additionally, microinflammation of hair follicles is a significant factor contributing to hair loss. IL-6 is a pro-inflammatory factor that can damage the structure of hair follicles, leading to the apoptosis of hair papilla cells [28,29]. In the experimental groups with low, medium, and high doses of LWE and SMWE, the relative expression levels of IL-6 mRNA in HDPCs were reduced, but these changes were not statistically significant (Figure 8a,b). The low, medium, and high doses of EWE significantly inhibited the expression of the inflammatory factor IL-6 (p < 0.001), resulting in reductions of 53.38%, 63.50% and 52.78%, respectively (Figure 8d). Additionally, treatment with MLWE and CRWE, the low-dose experimental group effectively inhibited the expression of IL-6 (Figure 8c,e). However, as the concentration of the water extracts increased, the relative expression level of IL-6 mRNA rose.

3.9. Promoting Effect of LWE, SMWE, MLWE, EWE and CRWE on Expression of β-Catenin in HDPCs

The Wnt/β-catenin signaling pathway is one of the central signaling pathways involved in the transformation of the hair follicle from the telogen phase to the anagen phase. β-catenin is a key core member of this pathway and plays a crucial role in maintaining the hair follicle growth process [6]. As shown in Figure 9, the expression levels of β-catenin protein in HDPCs treated with different water extracts were determined through western blotting assay. The results indicated that, except for CRWE at 40 μg/mL, the expression levels of β-catenin were slightly elevated in response to the water extracts. Among them, the increase in β-catenin expression was dose-dependent for both LWE and SMWE.

4. Discussion

18-β-glycyrrhetinic acid in licorice extends the anagen phase by inhibiting the expression of TGF-β1, thereby promoting the proliferation of dermal papilla cells and outer root sheath cells [30]. According to previous reports, glycyrrhizic acid promotes the expression of β-catenin and VEGF, thereby stimulating the formation of neoplastic hair follicles on the back of mice [31]. Jin et al. [32] found that the Salvia plebeia extract activated the Wnt/β-catenin pathway by enhancing the expression of β-catenin and promoting the phosphorylation of GSK-3β. Furthermore, it increased the ratio of the anti-apoptotic proteins Bcl-2 to Bax. It activates hair follicle cells and induces an anagen phase in mice, thereby promoting hair growth. Tanshinone is the main component of Salvia plebeian. Joe et al. [33] found that tanshinone can effectively inhibit NADPH oxidase activity heightened by testosterone, thereby significantly increasing follicle length. Additionally, mulberry leaf possesses the effects of nourishing blood, moistening dryness and dispelling wind evils, which can promote hair growth [34]. Ephedra can enhance blood circulation in the scalp, improve local nutrient supply and contribute to the nourishment and health of the hair roots [35]. Malassezia is commonly present on the scalps of AGA patients [36], and tulip extract has been shown to inhibit the activity of Malassezia [37].
In this study, all water extracts showed higher expression of ALP compared to the MNX group. ALP shows high activity during hair follicle papilla development [12]. It was found that an increase in ALP activity could inhibit regression progression induced by ROS [38]. The Wnt/β-catenin signaling pathway plays a crucial role in the maintenance of the hair follicle cycle. The upregulation of β-catenin expression initiates the Wnt/β-catenin signaling cascade, promoting the proliferation and migration of hair papilla cells, resulting in the stimulation of hair growth [39].
As one of the pivotal factors influencing hair growth and longevity, studies have reported that VEGF can be produced through the activation of IGF-1 and its receptors, thereby promoting the proliferation of hair papilla cells [40,41]. In this study, LWE, SMWE, MLWE, EWE and CRWE all promoted VEGF secretion. Additionally, overexpression of VEGF can promote hair follicle growth as well as accelerate hair regrowth in mice [42].
Hair undergoes a cyclical process of growth, resting, shedding and regrowth as it progresses through the anagen, catagen and telogen phases of the hair follicle, with distinct genes exerting specific influences during each phase. TGF-β leads to the transition of hair follicles from the anagen phase to the catagen phase [32]. Previous studies have found that the inhibition of TGF-β1 expression promotes the proliferation of KC, thereby prolonging the anagen phase in mice [43]. Additionally, TGF-β2 is produced during the anagen–telogen transition and can induce apoptosis in ORC [44]. In this study, LWE, SMWE, MLWE, EWE and CRWE all inhibited TGF-β1 mRNA expression to varying degrees. The secretion of inflammatory factors can also inhibit hair growth [45]. LWE, SMWE and EWE effectively inhibited IL-6 expression. Furthermore, MLWE at concentrations of 5 μg/mL and 10 μg/mL, as well as CRWE at 5 μg/mL, were also capable of inhibiting IL-6 expression. IL-6, a paracrine factor of DPC, inhibits hair shaft elongation and accelerates the transition from anagen to telogen in mice [46].
In this study, we found that LWE, SMWE, MLWE, EWE and CRWE were able to promote hair growth to a certain extent through in vitro experiments. This finding suggests a potential source of natural plant medicines for the prevention of hair loss. However, our study has certain limitations. This research is limited to observations at the cellular level and has not been further investigated using ex vivo hair follicle models or animal models. Further research is needed to evaluate the efficacy and safety of LWE, SMWE, MLWE, EWE and CRWE in preventing hair loss.
In conclusion, our research findings suggest that LWE, SMWE, MLWE, EWE and CRWE may promote hair growth by activating the Wnt/β-catenin signaling pathway and inhibiting the TGFβ/BMP signaling pathway, thereby facilitating the transition to the anagen phase of hair growth. In addition, LWE, SMWE, MLWE and EWE can stimulate HDPCs to secrete VEGF. Furthermore, with the exception of CRWE, LWE, SMWE, MLWE and EWE may inhibit microinflammation in hair follicles by suppressing the expression of the pro-inflammatory factor IL-6. All five plant extracts demonstrated potential for combating hair loss. Therefore, LWE, SMWE, MLWE, EWE and CRWE can be added as plant extract additives in anti-hair loss products.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/cimb47010068/s1.

Author Contributions

Conceptualization, C.H.; data curation, J.X.; formal analysis, J.X.; funding acquisition, C.H.; investigation, J.X. and R.T.; methodology, J.X.; project administration, C.H.; resources, J.X.; software, J.X.; supervision, C.H.; validation, J.X.; visualization, J.X.; writing—original draft, J.X.; writing—review and editing, J.X. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the corresponding author upon request.

Acknowledgments

The authors acknowledge the support from Beijing Technology and Business University.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
BMPBone morphogenetic proteins
VEGFVascular endothelial growth factor
TGF-βTransforming growth factor beta
TGF-β1Transforming growth factor beta 1
TGF-β2Transforming growth factor beta 2
IL-6Interleukin 6
HDPCsHuman dermal papilla cells
ORCOuter root sheath cells
KCKeratinocytes

References

  1. Rushton, D.H.; Norris, M.J.; Dover, R.; Busuttil, N. Causes of hair loss and the developments in hair rejuvenation. Int. J. Cosmet. Sci. 2002, 24, 17–23. [Google Scholar] [CrossRef] [PubMed]
  2. Nilforoushzadeh, M.A.; Golparvaran, M. An assessment for measuring loneliness, anxiety, and depression in male patients with androgenetic alopecia undergoing hair transplantation surgery: A before-after study. J. Cosmet. Dermatol. 2022, 21, 7013–7017. [Google Scholar] [CrossRef] [PubMed]
  3. Choi, B.Y. Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss. Int. J. Mol. Sci. 2020, 21, 4915. [Google Scholar] [CrossRef] [PubMed]
  4. Zhou, L.J.; Wang, H.; Jing, J.; Yu, L.J.; Wu, X.J.; Lu, Z.F. Morroniside regulates hair growth and cycle transition via activation of the Wnt/β-catenin signaling pathway. Sci. Rep. 2018, 8, 13785. [Google Scholar] [CrossRef]
  5. Xing, F.; Yi, W.J.; Miao, F.; Su, M.Y.; Lei, T.C. Baicalin increases hair follicle development by increasing canonical Wnt/β-catenin signaling and activating dermal papillar cells in mice. Int. J. Mol. Med. 2018, 41, 2079–2085. [Google Scholar] [CrossRef] [PubMed]
  6. Wang, X.X.; Liu, Y.H.; He, J.; Wang, J.R.; Chen, X.D.; Yang, R.H. Regulation of signaling pathways in hair follicle stem cells. Burns Trauma 2022, 10, tkac022. [Google Scholar] [CrossRef] [PubMed]
  7. Wu, X.C.; Du, Y.Z. Nanodrug Delivery Strategies to Signaling Pathways in Alopecia. Mol. Pharm. 2023, 20, 5396–5415. [Google Scholar] [CrossRef] [PubMed]
  8. Hwang, I.; Choi, K.A.; Park, H.S.; Jeong, H.; Kim, J.O.; Seol, K.C.; Kwon, H.J.; Park, I.H.; Hong, S. Neural Stem Cells Restore Hair Growth Through Activation of the Hair Follicle Niche. Cell Transplant. 2016, 25, 1439–1451. [Google Scholar] [CrossRef] [PubMed]
  9. Hong, G.L.; Lee, H.J.; Kim, Y.J.; Kim, K.H.; Jung, J.Y. Stauntonia hexaphylla Extract Ameliorates Androgenic Alopecia by Inhibiting Androgen Signaling in Testosterone-induced Alopecia Mice. Iran. Ran. J. Pharm. Res. 2022, 21, e133333. [Google Scholar] [CrossRef] [PubMed]
  10. Wu, P.; Zhang, Y.M.; Xing, Y.Z.; Xu, W.; Guo, H.Y.; Deng, F.; Ma, X.G.; Li, Y.H. The balance of Bmp6 and Wnt10b regulates the telogen-anagen transition of hair follicles. Cell Commun. Signal. 2020, 17, 16. [Google Scholar] [CrossRef] [PubMed]
  11. Lee, W.S. Integral hair lipid in human hair follicle. J. Dermatol. Sci. 2011, 64, 153–158. [Google Scholar] [CrossRef]
  12. Bernard, B.A. The hair follicle enigma. Exp. Dermatol. 2017, 26, 472–477. [Google Scholar] [CrossRef] [PubMed]
  13. van de Lavoir, M.; da Silva, K.M.; Iturrospe, E.; Robeyns, R.; van Nuijs, A.L.N.; Covaci, A. Untargeted hair lipidomics: Comprehensive evaluation of the hair-specific lipid signature and considerations for retrospective analysis. Anal. Bioanal. Chem. 2023, 415, 5589–5604. [Google Scholar] [CrossRef]
  14. Yu, X.Q.; He, C.F.; Tian, Y. Study on hair root lipids of female androgenetic alopecia based on UPLC-Q-TOF/MS results. J. Eur. Acad. Dermatol. Venereol. 2023, 37, E593–E596. [Google Scholar] [CrossRef] [PubMed]
  15. Randolph, M.; Tosti, A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. J. Am. Acad. Dermatol. 2020, 84, 737–746. [Google Scholar] [CrossRef] [PubMed]
  16. Gupta, A.K.; Venkataraman, M.; Talukder, M.; Bamimore, M.A. Finasteride for hair loss: A review. J. Dermatol. Treat. 2022, 33, 1938–1946. [Google Scholar] [CrossRef] [PubMed]
  17. Gasmi, A.; Mujawdiya, P.K.; Beley, N.; Shanaida, M.; Lysiuk, R.; Lenchyk, L.; Noor, S.; Muhammad, A.; Strus, O.; Piscopo, S.; et al. Natural Compounds used for Treating Hair Loss. Curr. Pharm. Des. 2023, 29, 1231–1244. [Google Scholar] [CrossRef]
  18. Shen, Y.L.; Li, X.Q.; Pan, R.R.; Yue, W.; Zhang, L.J.; Zhang, H. Medicinal Plants for the Treatment of Hair Loss and the Suggested Mechanisms. Curr. Pharm. Des. 2018, 24, 3090–3100. [Google Scholar] [CrossRef]
  19. Boezio, B.; Audouze, K.; Ducrot, P.; Taboureau, O. Network-based Approaches in Pharmacology. Mol. Inform. 2017, 36, 1700048. [Google Scholar] [CrossRef] [PubMed]
  20. Duan, X.C.; Wang, N.; Peng, D.Y. Application of network pharmacology in synergistic action of Chinese herbal compounds. Theory Biosci. 2024, 143, 195–203. [Google Scholar] [CrossRef]
  21. Chen, H.B.; Zhang, X.H.; Li, J.Y.; Xu, Z.; Luo, Y.W.; Chai, R.D.; Luo, R.Z.; Bian, Y.H.; Liu, Y.H. Discovering Traditional Chinese Medicine (TCM) Formulas for Complex Diseases Based on a Combination of Reverse Systematic Pharmacology and TCM Meridian Tropism Theory: Taking COVID-19 as an Example. ACS Omega. 2023, 8, 26871–26881. [Google Scholar] [CrossRef] [PubMed]
  22. Dan, W.; Liu, J.; Guo, X.; Zhang, B.; Qu, Y.; He, Q. Study on Medication Rules of Traditional Chinese Medicine against Antineoplastic Drug-Induced Cardiotoxicity Based on Network Pharmacology and Data Mining. Evid. Based Complement. Alternat. Med. 2020, 2020, 7498525. [Google Scholar] [CrossRef] [PubMed]
  23. Lee, S.H.; Yoon, J.; Shin, S.H.; Zahoor, M.; Kim, H.J.; Park, P.J.; Park, W.S.; Min, D.S.; Kim, H.Y.; Choi, K.Y. Valproic Acid Induces Hair Regeneration in Murine Model and Activates Alkaline Phosphatase Activity in Human Dermal Papilla Cells. PLoS ONE 2012, 7, e34152. [Google Scholar] [CrossRef] [PubMed]
  24. Ding, Y.W.; Li, Y.; Zhang, Z.W.; Dao, J.W.; Wei, D.X. Hydrogel forming microneedles loaded with VEGF and Ritlecitinib/polyhydroxyalkanoates nanoparticles for mini-invasive androgenetic alopecia treatment. Bioact. Mater. 2024, 38, 95–108. [Google Scholar] [CrossRef] [PubMed]
  25. Park, S.M.; He, Y.C.; Gong, C.; Gao, W.; Bae, Y.S.; Si, C.L.; Park, K.H.; Choi, S.E. Effects of taxifolin from enzymatic hydrolysis of Rhododendron mucrotulatum on hair growth promotion. Front. Bioeng. Biotechnol. 2022, 10, 995238. [Google Scholar] [CrossRef] [PubMed]
  26. Jia, S.J.; Meng, A.M. TGFβ family signaling and development. Development 2021, 148, dev188490. [Google Scholar] [CrossRef] [PubMed]
  27. Kang, J.I.; Choi, Y.K.; Han, S.C.; Nam, H.; Lee, G.; Kang, J.H.; Koh, Y.S.; Hyun, J.W.; Yoo, E.S.; Kang, H.K. 5-Bromo-3,4-dihydroxybenzaldehyde Promotes Hair Growth through Activation of Wnt/β-Catenin and Autophagy Pathways and Inhibition of TGF-β Pathways in Dermal Papilla Cells. Molecules 2022, 27, 2176. [Google Scholar] [CrossRef] [PubMed]
  28. Kong, J.; Qiang, W.D.; Jiang, J.Y.; Hu, X.L.; Chen, Y.N.; Guo, Y.X.; Liu, H.X.; Sun, S.M.; Gao, H.T.; Zhang, Y.; et al. Safflower oil body nanoparticles deliver hFGF10 to hair follicles and reduce microinflammation to accelerate hair regeneration in androgenetic alopecia. Int. J. Pharm. 2022, 616, 121537. [Google Scholar] [CrossRef]
  29. Wisuitiprot, V.; Ingkaninan, K.; Chakkavittumrong, P.; Wisuitiprot, W.; Neungchamnong, N.; Chantakul, R.; Waranuch, N. Effects of Acanthus ebracteatus Vahl. extract and verbascoside on human dermal papilla and murine macrophage. Sci. Rep. 2022, 12, 1491. [Google Scholar] [CrossRef]
  30. Hagiwara, K.; Kiso, A.; Ono, S.; Kitamura, H.; Yamanishi, H.; Tsunekawa, Y.; Iwabuchi, T. 18-β-Glycyrrhetinic Acid Promotes Hair Growth by Stimulating the Proliferation of Dermal Papilla Cells and Outer Root Sheath Cells, and Extends the Anagen Phase by Inhibiting 5α-Reductase. Biol. Pharm. Bull. 2024, 47, 1392–1395. [Google Scholar] [CrossRef]
  31. Zhang, B.; Zhang, W.Y.; Luo, J.F.; He, J.; Rong, B.S.; Zheng, X.M.; Zhu, S.Y.; Xu, X.; Ai, Y.; Zhang, L.Y.; et al. Evaluation of Hair Growth Properties of Glycyrrhizic Acid. Pharmacogn. Mag. 2022, 18, 1111–1117. [Google Scholar] [CrossRef]
  32. Jin, G.R.; Zhang, Y.L.; Yap, J.; Boisvert, W.A.; Lee, B.H. Hair growth potential of Salvia plebeia extract and its associated mechanisms. Pharm. Biol. 2020, 58, 400–409. [Google Scholar] [CrossRef] [PubMed]
  33. Yeo Kyu, H.; Jin Yeong, C.; Min Hye, C.; Kkotnara, P.; Da-Woon, B.; Soo-Bong, P.; Sun-Shin, C.; Hye Eun, L.; In Hye, L.; Yun Soo, B. Tanshinone, a Natural NADPH Oxidase Inhibitor, Mitigates Testosterone-Induced Hair Loss. Biomol. Ther. 2024, 33, 210. [Google Scholar] [CrossRef]
  34. Wang, K.X.; Lu, B.P. Mao Dexi′s Experience in Clinical Application of Sangye (Mori Folium). Acta Chin. Med. 2024, 39, 1941–1944. [Google Scholar]
  35. Fang, M.D.; Tan, L.X. The Application of Matched Pair of Ephedra and Other Medicines to Paediatrics. J. Shaanxi Univ. Chin. Med. 2018, 41, 115–117. [Google Scholar]
  36. Suzuki, K.; Inoue, M.; Cho, O.; Mizutani, R.; Shimizu, Y.; Nagahama, T.; Sugita, T. Scalp Microbiome and Sebum Composition in Japanese Male Individuals with and without Androgenetic Alopecia. Microorganisms 2021, 9, 2132. [Google Scholar] [CrossRef]
  37. Chen, Q.S.; He, J.Y.; Meng, X.; Li, Q.; Gong, S.Z. Study on Anti-hair Loss and Anti-dandruff Effect of Active Extract from Three Kinds of Zingiberaceae. Guangdong Chem. Ind. 2021, 48, 70–72+69. [Google Scholar]
  38. Park, B.; Kim, D.; Zhao, H.R.; Kim, S.; Park, B.C.; Lee, S.; Lee, Y.; Park, H.D.; Lim, D.; Ryu, S.; et al. Glycogen Phosphorylase Inhibitor Promotes Hair Growth via Protecting from Oxidative-Stress and Regulating Glycogen Breakdown in Human Hair follicles. Biomol. Ther. 2024, 32, 640–646. [Google Scholar] [CrossRef] [PubMed]
  39. Muangsanguan, A.; Ruksiriwanich, W.; Arjin, C.; Jamjod, S.; Prom-u-Thai, C.; Jantrawut, P.; Rachtanapun, P.; Hnorkaew, P.; Satsook, A.; Sainakham, M.; et al. Comparison of In Vitro Hair Growth Promotion and Anti-Hair Loss Potential of Thai Rice By-Product from Oryza sativa L. cv. Buebang 3 CMU and Sanpatong. Plants 2024, 13, 3079. [Google Scholar] [CrossRef]
  40. Kubanov, A.A.; Gallyamova, Y.A.; Korableva, O.A.; Kalinina, P.A. The Role of the VEGF, KGF, EGF, and TGF-Β1Growth factors in the Pathogenesis of Telogen Effluvium in Women. Biomed. Pharmacol. J. 2017, 10, 191–198. [Google Scholar] [CrossRef]
  41. Nakamura, T.; Yamamura, H.; Park, K.; Pereira, C.; Uchida, Y.; Horie, N.; Kim, M.; Itami, S. Naturally Occurring Hair Growth Peptide: Water-Soluble Chicken Egg Yolk Peptides Stimulate Hair Growth Through Induction of Vascular Endothelial Growth Factor Production. J. Med. Food 2018, 21, 701–708. [Google Scholar] [CrossRef] [PubMed]
  42. Lee, C.Y.; Su, C.H.; Chiang, C.Y.; Wu, C.N.; Kuan, Y.H. Observation of the Expression of Vascular Endothelial Growth Factor and the Potential Effect of Promoting Hair Growth Treated with Chinese Herbal BeauTop. Evid. Based Complement. Alternat. Med. 2021, 2021, 6667011. [Google Scholar] [CrossRef] [PubMed]
  43. Begum, S.; Lee, M.R.; Gu, L.J.; Hossain, J.; Sung, C.K. Exogenous stimulation with Eclipta alba promotes hair matrix keratinocyte proliferation and downregulates TGF-β1 expression in nude mice. Int. J. Mol. Med. 2015, 35, 496–502. [Google Scholar] [CrossRef] [PubMed]
  44. An, S.Y.; Kim, H.S.; Kim, S.Y.; Van, S.Y.; Kim, H.J.; Lee, J.H.; Han, S.W.; Kwon, I.; Lee, C.K.; Do, S.H.; et al. Keratin-mediated hair growth and its underlying biological mechanism. Commun. Biol. 2022, 5, 1270. [Google Scholar] [CrossRef] [PubMed]
  45. Qiu, S.T.; Pan, Z.; Jiang, X.; Lv, G.W.; Feng, A.Q.; Chen, H.B. The synergistic effect of phototherapy and active substances on hair growth. J. Photochem. Photobiol. B 2024, 259, 113008. [Google Scholar] [CrossRef] [PubMed]
  46. Kwack, M.H.; Ahn, J.S.; Kim, M.K.; Kim, J.C.; Sung, Y.K. Dihydrotestosterone-Inducible IL-6 Inhibits Elongation of Human Hair Shafts by Suppressing Matrix Cell Proliferation and Promotes Regression of Hair Follicles in Mice. J. Investig. Dermatol. 2012, 132, 43–49. [Google Scholar] [CrossRef]
Figure 1. Venn diagram of intersecting targets of key differential lipids and alopecia.
Figure 1. Venn diagram of intersecting targets of key differential lipids and alopecia.
Cimb 47 00068 g001
Figure 2. Key targets–active ingredients–plant raw materials network (plant raw materials degree ≥ 60). The green nodes represent active ingredients, the blue nodes represent plant raw materials, and the red nodes represent targets. The edges represent the interactions between them, and node sizes are proportional to their degree.
Figure 2. Key targets–active ingredients–plant raw materials network (plant raw materials degree ≥ 60). The green nodes represent active ingredients, the blue nodes represent plant raw materials, and the red nodes represent targets. The edges represent the interactions between them, and node sizes are proportional to their degree.
Cimb 47 00068 g002
Figure 3. Lipids–key targets–active ingredients–plant raw materials network (plant raw materials degree ≥ 30). The green nodes represent active ingredients, the blue nodes represent plant raw materials, red nodes represent targets, and the yellow nodes represent lipids. The edges represent the interactions between them, and node size are proportional to their degree.
Figure 3. Lipids–key targets–active ingredients–plant raw materials network (plant raw materials degree ≥ 30). The green nodes represent active ingredients, the blue nodes represent plant raw materials, red nodes represent targets, and the yellow nodes represent lipids. The edges represent the interactions between them, and node size are proportional to their degree.
Cimb 47 00068 g003
Figure 4. Venn diagram of intersecting plant raw materials of key differential lipids and key pathways.
Figure 4. Venn diagram of intersecting plant raw materials of key differential lipids and key pathways.
Cimb 47 00068 g004
Figure 5. The effect of (a) LWE, (b) SMWE, (c) MLWE, (d) EWE and (e) CRWE at 0, 5, 10, 20, 40, 60, 80, 160 or 320 μg/mL on the cell viability of HDPCs was measured by CCK-8 assay. Results are presented as mean ± standard deviation of the mean. * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. control group. LWE, licquorice water extract; SMWE, salvia miltiorrhiza water extract; MLWE, mulberry leaf water extract; EWE, ephedra water extract; CRWE, curcumae radix water extract.
Figure 5. The effect of (a) LWE, (b) SMWE, (c) MLWE, (d) EWE and (e) CRWE at 0, 5, 10, 20, 40, 60, 80, 160 or 320 μg/mL on the cell viability of HDPCs was measured by CCK-8 assay. Results are presented as mean ± standard deviation of the mean. * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. control group. LWE, licquorice water extract; SMWE, salvia miltiorrhiza water extract; MLWE, mulberry leaf water extract; EWE, ephedra water extract; CRWE, curcumae radix water extract.
Cimb 47 00068 g005
Figure 6. ALP expression level of HDPCs after treatment with (a) LWE (0, 5, 10, 20 or 40 μg/mL), (b) SMWE (0, 5, 10, 20 or 40 μg/mL), (c) MLWE (0, 5, 10, 20 or 40 μg/mL), (d) EWE (0, 5, 10, 20 or 40 μg/mL) and (e) CRWE (0, 5, 10, 40 or 60 μg/mL) (n = 4). Results are presented as mean ± standard deviation of the mean. * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. control group.
Figure 6. ALP expression level of HDPCs after treatment with (a) LWE (0, 5, 10, 20 or 40 μg/mL), (b) SMWE (0, 5, 10, 20 or 40 μg/mL), (c) MLWE (0, 5, 10, 20 or 40 μg/mL), (d) EWE (0, 5, 10, 20 or 40 μg/mL) and (e) CRWE (0, 5, 10, 40 or 60 μg/mL) (n = 4). Results are presented as mean ± standard deviation of the mean. * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. control group.
Cimb 47 00068 g006aCimb 47 00068 g006b
Figure 7. VEGF expression level of HDPCs after treatment with LWE (5, 10 or 40 μg/mL), SMWE (10, 20 or 40 μg/mL), MLWE (5, 10 or 40 μg/mL), EWE (5, 10 or 40 μg/mL), CRWE (5, 10 or 60 μg/mL) and MNX (5 or 10 μM). Results are presented as mean ± standard deviation of the mean. * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. control group.
Figure 7. VEGF expression level of HDPCs after treatment with LWE (5, 10 or 40 μg/mL), SMWE (10, 20 or 40 μg/mL), MLWE (5, 10 or 40 μg/mL), EWE (5, 10 or 40 μg/mL), CRWE (5, 10 or 60 μg/mL) and MNX (5 or 10 μM). Results are presented as mean ± standard deviation of the mean. * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. control group.
Cimb 47 00068 g007
Figure 8. TGF-β1 and IL-6 expression level of HDPCs after treatment with (a) LWE (0, 5, 10 or 40 μg/mL), (b) SMWE (0, 10, 20 or 60 μg/mL), (c) MLWE (0, 5, 10 or 40 μg/mL), (d) EWE (0, 5, 10 or 40 μg/mL), (e) CRWE (0, 5, 10 or 60 μg/mL) and (f) MNX (0, 5 or 10 μM). Results are presented as mean ± standard deviation of the mean. * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. control group.
Figure 8. TGF-β1 and IL-6 expression level of HDPCs after treatment with (a) LWE (0, 5, 10 or 40 μg/mL), (b) SMWE (0, 10, 20 or 60 μg/mL), (c) MLWE (0, 5, 10 or 40 μg/mL), (d) EWE (0, 5, 10 or 40 μg/mL), (e) CRWE (0, 5, 10 or 60 μg/mL) and (f) MNX (0, 5 or 10 μM). Results are presented as mean ± standard deviation of the mean. * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. control group.
Cimb 47 00068 g008
Figure 9. Protein expression levels of β-catenin was evaluated by western blot analysis (a). Results are presented as mean ± standard deviation of the mean (b). * p < 0.05 vs. control group.
Figure 9. Protein expression levels of β-catenin was evaluated by western blot analysis (a). Results are presented as mean ± standard deviation of the mean (b). * p < 0.05 vs. control group.
Cimb 47 00068 g009
Table 1. Primer sequences.
Table 1. Primer sequences.
Primer NamePrimer Sequences
GAPDHF: GGAGCGAGATCCCTCCAAAAT
R: GGCTGTTGTCATACTTCTCATGG
TGF-β1F: GCAACAATTCCTGGCGATACCTC
R: CCTCCACGGCTCAACCACTG
IL-6F: AGGGCTCTTCGGCAAATGTA
R: GAAGGAATGCCCATTAACAACAA
Table 2. Information on the top 9 active ingredients in terms of degree value based on key pathway targets.
Table 2. Information on the top 9 active ingredients in terms of degree value based on key pathway targets.
NumberHERB IDIngredientDegreePumChem IDMWLog PH Bond DonorH Bond Acceptor Rotbonds
1HBIN00199117-beta-estradiol135757272.44220
2HBIN046831trans-resveratrol11445154228.243.1332
3HBIN028102glycerin975392.09−1.8332
4HBIN020984citric acid8311192.12−1.7475
5HBIN041721quercetin65280343302.231.5571
6HBIN040799progesterone55994314.53.9021
7HBIN029342hexose4439357180.16−2.6561
8HBIN00198717alpha-estradiol468570272.44220
Table 3. Information on the top 9 active ingredients in terms of degree value based on key differential lipids.
Table 3. Information on the top 9 active ingredients in terms of degree value based on key differential lipids.
NumberHERB IDIngredientDegreePumChem IDMWLog PH Bond DonorH Bond Acceptor Rotbonds
1HBIN028102glycerin2675392.09−1.8332
2HBIN00199117-beta-estradiol255757272.44220
3HBIN041721quercetin195280343302.231.5571
4HBIN029342hexose18439357180.16−2.6561
5HBIN046831trans-resveratrol17445154228.243.1332
6HBIN025875ethyl aldehyde1317744.05−0.3010
7HBIN00198717alpha-estradiol1268570272.44220
8HBIN020389cholalic acid11221493408.63.6454
Table 4. The information of top 17 plant raw materials based on key pathway targets.
Table 4. The information of top 17 plant raw materials based on key pathway targets.
NumberHerbDegree
1Licorice66
2Corydalis yanhusuo51
3Salvia miltiorrhiza49
4Scutellaria pycnoclada39
5Lignum dalbergiae odoriferae33
6Mulberry leaf30
7Artemisia annua30
8Meadowrue root and rhizome29
9Celandine28
10Peucedanum pastinacifolium27
11Amur cork-tree bark27
12Ephedra27
13Millettia pseudoracemosa27
14Suberect spatholobus stem26
15Galangal26
16Rosewood heart wood25
17Curcumae radix25
Table 5. The information of top 17 plant raw materials based on key differential lipids.
Table 5. The information of top 17 plant raw materials based on key differential lipids.
NumberHerbDegree
1Ephedra157
2Commiphora myrrh146
3Perilla frutescens138
4Ginger137
5Chrysanthemum126
6Salvia miltiorrhiza124
7Radix Bupleuri124
8Coriandrum sativum120
9Mulberry leaf117
10Curcumae radix116
11Licorice110
12Cinnamomi ramulus108
13Notopterygium incisum107
14Villous amomum fruit107
15Magnoliae flos105
16Manchurian wild ginger105
17Peppermint102
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Xu, J.; He, C.; Tian, R. Screening of Anti-Hair Loss Plant Raw Materials Based on Reverse Network Pharmacology and Experimental Validation. Curr. Issues Mol. Biol. 2025, 47, 68. https://doi.org/10.3390/cimb47010068

AMA Style

Xu J, He C, Tian R. Screening of Anti-Hair Loss Plant Raw Materials Based on Reverse Network Pharmacology and Experimental Validation. Current Issues in Molecular Biology. 2025; 47(1):68. https://doi.org/10.3390/cimb47010068

Chicago/Turabian Style

Xu, Jiajia, Congfen He, and Rui Tian. 2025. "Screening of Anti-Hair Loss Plant Raw Materials Based on Reverse Network Pharmacology and Experimental Validation" Current Issues in Molecular Biology 47, no. 1: 68. https://doi.org/10.3390/cimb47010068

APA Style

Xu, J., He, C., & Tian, R. (2025). Screening of Anti-Hair Loss Plant Raw Materials Based on Reverse Network Pharmacology and Experimental Validation. Current Issues in Molecular Biology, 47(1), 68. https://doi.org/10.3390/cimb47010068

Article Metrics

Back to TopTop